Form 4: Alignment Healthcare CEO Sells 90,000 Shares Under Pre-Arranged Plan

Alignment Healthcare, Inc. CEO John E. Kao reported the sale of 90,000 shares of common stock for approximately $1.3 million, executed under a Rule 10b5-1 trading plan.

Summary

• John E. Kao, Chief Executive Officer and Director of Alignment Healthcare, Inc. (ALHC), reported a transaction involving the company's common stock.
• On June 16, 2025, Mr. Kao sold 90,000 shares of Alignment Healthcare common stock.
• The shares were sold at a weighted-average price of $14.4761 per share, totaling approximately $1,302,849.
• The sale was conducted pursuant to a Rule 10b5-1 plan, which was adopted on March 12, 2025.
• The per-share price for the sales ranged from $14.23 to $14.92.
• Following this transaction, Mr. Kao directly owns 4,923,186 shares of common stock.
• Additionally, Mr. Kao indirectly owns 1,733,100 shares through the JEK Trust, dated February 8, 2021, for which he serves as trustee.

Sentiment

Score: 5

Explanation: The document reports a pre-scheduled insider stock sale under a Rule 10b5-1 plan. While any insider sale can be viewed with slight caution, the pre-planned nature mitigates negative sentiment, making it a neutral event in terms of immediate company performance implications.

Negatives

• The sale of a significant number of shares by a Chief Executive Officer, even under a pre-arranged plan, can sometimes be perceived negatively by investors as it may suggest a lack of confidence, although this is often not the case with 10b5-1 plans.

Future Outlook

This document, an SEC Form 4, reports an insider transaction and does not contain forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This Form 4 filing reports a routine insider transaction under a pre-arranged trading plan, which is a common practice for executives to manage their equity holdings. It does not provide broader industry context or trends.

Related Party Transactions

• The reported transaction is a sale of common stock by John E. Kao, the Chief Executive Officer and a Director of Alignment Healthcare, Inc., making it a related party transaction.
• Mr. Kao's indirect beneficial ownership of 1,733,100 shares through the JEK Trust (dated February 8, 2021), for which he is the trustee, represents a related party holding.

Stakeholder Impact

• Shareholders: May observe the CEO's stock sale, which, despite being pre-planned, could lead to questions about management's confidence or personal financial planning. However, 10b5-1 plans are designed to avoid implications of trading on inside information.

Key Dates

Keywords

Alignment Healthcare, ALHC, John E. Kao, CEO, Director, Stock Sale, Insider Transaction, Form 4, Rule 10b5-1, Common Stock